Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Miguel-T. Hernández"'
Autor:
Noemí Puig, Cristina Agulló, Teresa Contreras, José-Juan Pérez, Irene Aires, María-José Calasanz, Ramón García-Sanz, Sergio Castro, Joaquín Martínez-López, Paula Rodríguez-Otero, Verónica González-Calle, Marta S González, Albert Oriol, Norma C Gutiérrez, Rafael Ríos-Tamayo, Laura Rosiñol, Miguel-Ángel Álvarez, Joan Bargay, Ana-Pilar González-Rodríguez, Adrián Alegre, Fernando Escalante, María-Belén Iñigo, Javier de la Rubia, Ana-Isabel Teruel, Felipe de Arriba, Luis Palomera, Miguel T Hernández, Javier López-Jiménez, Marta Reinoso, Aránzazu García-Mateo, Enrique M Ocio, Joan Bladé, Juan-José Lahuerta, María-Teresa Cedena, Bruno Paiva, Jesús F San Miguel, María-Victoria Mateos
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein is being investigated in patients with monoclonal gammopathies but no data are yet available in high-risk smoldering myeloma (HRsMM). We have therefore
Externí odkaz:
https://doaj.org/article/c81a444b8f6e434cb89c96b45ea2aec6
Autor:
Verónica González-Calle, Paula Rodríguez-Otero, Anna Sureda, Felipe de Arriba, Marta Reinoso, Paz Ribas, Ana Pilar González-Rodríguez, Yolanda González, Albert Oriol, Joaquín Martínez-López, Marta Sonia González, Miguel T. Hernández, Maialen Sirvent, Teresa Cedena, Noemí Puig, Bruno Paiva, Joan Bladé, Juan José Lahuerta, Jesús F. San-Miguel, María-Victoria Mateos
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The treatment landscape for multiple myeloma has significantly evolved in the last decade. Notwithstanding, a large proportion of patients continue to relapse and novel combinations continue to be needed. In this phase 2 study, selinexor, a first-in-
Externí odkaz:
https://doaj.org/article/ee8847a91f344d7fa309aa58a2634a3b
Autor:
Borja Puertas, Verónica González-Calle, Anna Sureda, María José Moreno, Albert Oriol, Esther González, Laura Rosiñol, Jordi López, Fernando Escalante, Joaquín Martínez-Lopez, Estrella Carrillo, Esther Clavero, Rafael Ríos-Tamayo, Beatriz Rey-Bua, Ana Pilar González-Rodríguez, Victoria Dourdil, Felipe de Arriba, Sonia González, Jaime Pérez-de-Oteyza, Miguel T. Hernández, Aránzazu García-Mateo, Joan Bargay, Joan Bladé, Juan José Lahuerta, Jesús F. San Miguel, Enrique M. Ocio, María-Victoria Mateos
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
In this randomized phase II study (GEM-KyCyDex, clinicaltrials gov. Identifier: NCT03336073), the combination of weekly carfilzomib 70 mg/m2, cyclophosphamide and dexamethasone (KCd) was compared to carfilzomib and dexamethasone (Kd) in relapsed/refr
Externí odkaz:
https://doaj.org/article/a973b16234c247c6bee670237e99afa7
Autor:
Noemi Puig, Miguel T. Hernández, Laura Rosiñol, Esther González, Felipe de Arriba, Albert Oriol, Verónica González-Calle, Fernando Escalante, Javier de la Rubia, Mercedes Gironella, Rafael Ríos, Ricarda García-Sánchez, José M. Arguiñano, Adrián Alegre, Jesús Martín, Norma. C. Gutiérrez, María J. Calasanz, María L. Martín, María del Carmen Couto, María Casanova, Mario Arnao, Ernesto Pérez-Persona, Sebastián Garzón, Marta S. González, Guillermo Martín-Sánchez, Enrique M. Ocio, Morton Coleman, Cristina Encinas, Ana M. Vale, Ana I. Teruel, María Cortés-Rodríguez, Bruno Paiva, M. Teresa Cedena, Jesús F. San-Miguel, Juan J. Lahuerta, Joan Bladé, Ruben Niesvizky, María-Victoria Mateos
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-11 (2021)
Abstract Although case-control analyses have suggested an additive value with the association of clarithromycin to continuous lenalidomide and dexamethasone (Rd), there are not phase III trials confirming these results. In this phase III trial, 286 p
Externí odkaz:
https://doaj.org/article/fb9a610fa208459ba3fc58d65716e220
Autor:
M. Pardina-Echevarría, O.R. Díaz-Sánchez, Sunil Lakhwani, Miguel T. Hernández-García, R. Arcas-Vega, José María Raya
Publikováno v:
Revista Clínica Española (English Edition). 222:169-173
Objectives This work aims to describe the proportion of patients with polycythemia vera (PV) or essential thrombocythemia (ET) and thrombosis prior to the diagnosis who had erythrocytosis or thrombocytosis prior to the thrombosis. Patients and method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b11e12e4d4595e174a0e33736aa86722
https://doi.org/10.1016/j.rceng.2021.07.003
https://doi.org/10.1016/j.rceng.2021.07.003
Autor:
R. Arcas-Vega, M. Pardina-Echevarría, José María Raya, Sunil Lakhwani, O.R. Díaz-Sánchez, Miguel T. Hernández-García
Publikováno v:
Revista Clínica Española. 222:169-173
Resumen Objetivos Describir la proporcion de pacientes con policitemia vera (PV) o trombocitemia esencial (TE) y trombosis previa al diagnostico que presentaban eritrocitosis o trombocitosis antes de la trombosis. Pacientes y metodos Revision retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a15dd4e5c078712712055023ae8b06c
https://doi.org/10.1016/j.rce.2021.07.002
https://doi.org/10.1016/j.rce.2021.07.002
Autor:
Yanira Ruiz-Heredia, Beatriz Sánchez-Vega, Esther Onecha, Santiago Barrio, Rafael Alonso, Jose Carlos Martínez-Ávila, Isabel Cuenca, Xabier Agirre, Esteban Braggio, Miguel-T. Hernández, Rafael Martínez, Laura Rosiñol, Norma Gutierrez, Marisa Martin-Ramos, Enrique M. Ocio, María-Asunción Echeveste, Jaime Pérez de Oteyza, Albert Oriol, Joan Bargay, Mercedes Gironella, Rosa Ayala, Joan Bladé, María-Victoria Mateos, Klaus M. Kortum, Keith Stewart, Ramón García-Sanz, Jesús San Miguel, Juan José Lahuerta, Joaquín Martinez-Lopez
Publikováno v:
Haematologica, Vol 103, Iss 11 (2018)
Externí odkaz:
https://doaj.org/article/1d4b5571ec4a4e94a391e5aa55a3910e
Autor:
Ramón García-Sanz, Albert Oriol, María J. Moreno, Javier de la Rubia, Angel R. Payer, Miguel T. Hernández, Luis Palomera, Ana I. Teruel, María J. Blanchard, Mercedes Gironella, Paz Ribas, Joan Bargay, Eugenia Abellá, Miquel Granell, Enrique M. Ocio, Josep M. Ribera, Jesús F. San Miguel, María V. Mateos
Publikováno v:
Haematologica, Vol 100, Iss 9 (2015)
This study analyzed the anti-myeloma effect of zoledronic acid monotherapy by investigating patients at the time of asymptomatic biochemical relapse. One hundred patients were randomized to receive either zoledronic acid (4 mg iv/4 weeks, 12 doses) (
Externí odkaz:
https://doaj.org/article/8c962edeaa324004b403bd8c5e275f3a
Autor:
Armando, López-Guillermo, Miguel Ángel, Canales, Ivan, Dlouhy, Santiago, Mercadal, Javier, Briones, Alejandro, Martín García-Sancho, Juan Manuel, Sancho, José María, Moraleda, María José, Terol, Antonio, Salar, Luis, Palomera, Santiago, Gardella, Isidro, Jarque, Secundino, Ferrer, Joan, Bargay, Andrés, López, Carlos, Panizo, Anna, Muntañola, Carlos, Montalbán, Eulogio, Conde, Miguel T, Hernández, Alfons, Soler, José A, García Marco, Guillermo, Deben, Julián, Marín, José Francisco, Tomás
Publikováno v:
Leukemialymphoma. 63(1)
This is a randomized phase-2 trial aimed to compare consolidation vs. maintenance in untreated patients with follicular lymphoma (FL) responding to induction. 146 patients were enrolled from 25 Spanish institutions (ZAR2007; ClinicalTrials.gov #NCT00
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3157e7aeddbb91b36ad9d90f08f84c34
https://pubmed.ncbi.nlm.nih.gov/34459702
https://pubmed.ncbi.nlm.nih.gov/34459702
Autor:
Javier Lopez Jimenez, Alejandro Martín, Carmen Albo, Reyes Arranz, Antonia Rodriguez, Luis Palomera, Sabela Bobillo, Lucrecia Yáñez, Isidro Jarque, Dolores Caballero, Armando López-Guillermo, José M. Moraleda, Juan José Lahuerta, Erika Coria, Santiago Mercadal, Carlos Vallejo, Antonio Salar, Laura Magnano, Leyre Lorza, Miguel T. Hernández-García, José Javier Ferreiro, Ana Jiménez-Ubieto, Silvana Novelli, Andrea Galeo, María Manzanares, Carlos Grande, Carmen Marrero, Elena Pérez
Publikováno v:
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Hematology/Oncology and Stem Cell Therapy, Vol 12, Iss 4, Pp 194-203 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Universidad de Zaragoza
Hematology/Oncology and Stem Cell Therapy, Vol 12, Iss 4, Pp 194-203 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Objective/Background: Patients with follicular lymphoma (FL) with early therapy failure (ETF) within 2 years of frontline therapy have poor overall survival (OS). We recently reported the results of autologous stem cell transplantation (ASCT) in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25351f2fdb0dc6091b51e9c409fd51fd
https://doi.org/10.1016/j.hemonc.2019.06.001
https://doi.org/10.1016/j.hemonc.2019.06.001